Storia in 2 fonti

FDA Approves New Blood Test for Colon Cancer Screening

SimpleScreen CRC is indicated for adults 45 and up at average risk

Raccontata da

medpagetoday.com

healio.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

medpagetoday.comStai leggendo19 g fa

FDA Approves New Blood Test for Colon Cancer Screening

SimpleScreen CRC is indicated for adults 45 and up at average risk

originale

healio.com18 g fa

FDA approves blood-based SimpleScreen CRC test for colorectal cancer surveillance

The FDA has approved a second blood-based colorectal cancer screening option for adults aged 45 years and older at average risk for the disease.SimpleScreen CRC (Freenome) is a noninvasive test that assesses cell-free…

Leggi questa versione → originale

Timeline cronologica

lunedì 27 luglio 2026·medpagetoday.com
FDA Approves New Blood Test for Colon Cancer Screening
SimpleScreen CRC is indicated for adults 45 and up at average risk
martedì 28 luglio 2026·healio.com
FDA approves blood-based SimpleScreen CRC test for colorectal cancer surveillance
The FDA has approved a second blood-based colorectal cancer screening option for adults aged 45 years and older at average risk for the disease.SimpleScreen CRC (Freenome) is a…